GURU.Markets stock price, segment price, and overall market index valuation
The company's share price AlphaTON Capital
Portage, a biotech company with a unique asset discovery and development model, shares reflect the success of its portfolio companies. Its price trajectory is a bet on its team's ability to identify and advance promising oncology developments.
Share prices of companies in the market segment - Crypto
Portage Biotech is an oncology company that discovers and develops new immunotherapeutic drugs through its portfolio of subsidiaries. We've classified it as "Crypto" (likely a miscategorization). The chart below shows the dynamics of the biotech incubator sector.
Broad Market Index - GURU.Markets
Portage Biotech is an oncology company that invests in and develops a portfolio of promising cancer drug candidates. As a unique player, it is included in our GURU.Markets index. The chart below shows the overall market trend. Compare it with Portage's performance to assess the state of the sector.
Change in the price of a company, segment, and market as a whole per day
ATON - Daily change in the company's share price AlphaTON Capital
For AlphaTON Capital, a biotechnology investor, daily volatility reflects its sensitivity to the successes and failures of its portfolio companies. This metric is an indicator of the effectiveness of its venture capital strategy in the life sciences sector.
Daily change in the price of a set of shares in a market segment - Crypto
Portage Biotech operates in the immuno-oncology field, where volatility is built into the business model. The chart below shows the average daily fluctuations for the entire biotech sector. This benchmark allows investors to compare the risks and potential upside of the stock based on clinical trial results.
Daily change in the price of a broad market stock, index - GURU.Markets
AlphaTON Capital is a company operating in the cryptocurrency and blockchain technologies space. Its shares directly reflect the extreme volatility of the digital asset market. The movements of such companies act as a bridge through which "crypto storms" are carried into the stock market, amplifying its daily fluctuations.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization AlphaTON Capital
For AlphaTON Capital, which operates through the Portage Biotech brand, year-over-year performance tells the story of its unique oncology investment model. Its market cap change over the past 12 months reflects the progress of its subsidiaries, each developing its own drugs. The success of any one of these companies can drive growth for the entire company.
Annual dynamics of market capitalization of the market segment - Crypto
Portage, as a biotech company with a diversified portfolio, is a unique player. Its performance reflects the success of its various subsidiaries. Compared to the sector, its model diversifies risks but may lack the growth potential of companies with a single, successful blockbuster.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
AlphaTON Capital (Bioxytran) is a biotech company whose performance is unrelated to market cycles. Its shares move in sync with clinical trial news. Their trajectory reflects investors' faith in the success of its drugs, with any news potentially triggering a sharp rise or fall.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization AlphaTON Capital
AlphaTON, as its name suggests, is associated with cryptocurrency or blockchain. The value of such companies is extremely volatile. Their monthly fluctuations directly reflect crypto market sentiment, partnership news, and technological developments.
Monthly dynamics of market capitalization of the market segment - Crypto
AlphaTON Capital, formerly Portage Biotech, is a biotech company that invests in and develops a portfolio of oncology drugs. Its model is similar to a venture capital fund operating within a public company. The chart below shows the dynamics of the biotech sector, where this approach allows for risk diversification.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
AlphaTON Capital (formerly Portage Biotech) is a biotech company with a portfolio of developments. Its value is the sum of expectations for each project. Its shares are driven by news of clinical trials within the portfolio, and their performance is uncorrelated with the broader market.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization AlphaTON Capital
AlphaTON Capital, according to the linked website, is a biotech company. The weekly stock price of such companies is highly volatile and dependent on clinical trial data. *The Crypto category may be incorrect.*
Weekly dynamics of market capitalization of the market segment - Crypto
AlphaTON Capital invests in crypto and biotech assets. This chart allows you to assess how the fund's shares react to volatility in these sectors. Is its performance representative of the portfolio, or is one asset causing strong short-term fluctuations?
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
AlphaTON Capital, operating in the cryptocurrency space, lives by the laws of this volatile market. The chart clearly demonstrates how closely the company's weekly share price fluctuations are linked to movements in the digital asset market, which sets the tone for the entire sector.
Market capitalization of the company, segment and market as a whole
ATON - Market capitalization of the company AlphaTON Capital
Data on AlphaTON Capital (ATON) may be inaccurate, as the website portagebiotech.com is owned by another company. The chart for such a speculative stock would likely reflect the extreme volatility in the cryptocurrency market or biotech venture capital investments.
ATON - Share of the company's market capitalization AlphaTON Capital within the market segment - Crypto
AlphaTON Capital, formerly known as Portage Biotech, is a crypto holding company. Its share of the crypto sector's market capitalization reflects the value of its digital assets and investments. The company's share is a barometer of the crypto market's health and the success of its strategy for managing a portfolio of volatile assets.
Market capitalization of the market segment - Crypto
AlphaTON Capital, affiliated with Portage Biotech, operates in the crypto sector. How big is this revolutionary yet risky universe? The chart below shows the pulse of the entire crypto sector. Its extreme volatility reflects both the enormous hopes and the significant risks inherent in this young industry.
Market capitalization of all companies included in a broad market index - GURU.Markets
The urban development dynamics of AlphaTON Capital (formerly Portage Biotech) illustrates the biotech incubator's complex journey. Its market capitalization is the estimated value of the oncology development portfolio it is attempting to bring to clinical stage. This diagram illustrates the risky model of biotech asset discovery and development.
Book value capitalization of the company, segment and market as a whole
ATON - Book value capitalization of the company AlphaTON Capital
For AlphaTON Capital (Portage Biotech), an oncology company, book value is its tangible asset base, consisting of a portfolio of investments in promising drug candidates and financial reserves for advancing them through clinical trials. The chart below shows how the value of this portfolio has changed.
ATON - Share of the company's book capitalization AlphaTON Capital within the market segment - Crypto
AlphaTON Capital (likely private/defunct) – its work in the crypto sector requires a tangible asset base. This could include mining farms, staking servers, or offices for analytics. The chart will show how its physical assets compare to its ambitions in the world of digital finance.
Market segment balance sheet capitalization - Crypto
AlphaTON Capital likely operates in the cryptocurrency space. Compared to the capital-intensive financial sector, it's "asset-light." The industry's asset chart mirrors bank balance sheets. Its infrastructure is likely an IT platform rather than physical assets.
Book value of all companies included in the broad market index - GURU.Markets
AlphaTON Capital (formerly Portage) is not a single company, but a portfolio of investments in several biotech startups it helps develop. Its book value reflects the total capital this "biotech incubator" has invested in its subsidiary projects.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - AlphaTON Capital
AlphaTON Capital (formerly Portage Biotech) is a biotech incubator. Its market valuation is the sum of its investments in various biotech startups. The chart shows how the market values its portfolio and its ability to select and develop promising scientific projects.
Market to book capitalization ratio in a market segment - Crypto
AlphaTON Capital (formerly Portage Biotech) is a holding company investing in various projects, including cryptocurrencies. The chart shows how the market evaluates its investment portfolio and its ability to identify promising assets, comparing capitalization to the book value of investments.
Market to book capitalization ratio for the market as a whole
AlphaTON Capital (formerly Portage Biotech) is a biotech incubator. Its value is derived from its portfolio of stakes in promising startups and the team's expertise. This chart shows how the market values biotech holdings, where value is created through the successful selection and development of multiple projects.
Debts of the company, segment and market as a whole
ATON - Company debts AlphaTON Capital
AlphaTON Capital, despite its name, is associated with biotechnology. For a development-stage biotech company, capital is a vital resource for funding research and clinical trials. This chart shows how the company raises funds to support its scientific programs, which are its core assets but do not generate revenue.
Market segment debts - Crypto
AlphaTON Capital (formerly Portage Biotech) is a holding company investing in biotech developments. Its financial structure reflects its investment portfolio, and its balance sheet shows how it finances the acquisition of stakes in promising projects. This chart provides insight into its investment strategy.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio AlphaTON Capital
AlphaTON Capital, as its former name (Portage Biotech) suggests, is a biotech company. This chart shows its financial structure. For biotech, especially in the early stages, debt is a huge risk. Financing should come from equity capital to ensure the company can survive the long clinical development process without pressure from creditors.
Market segment debt to market segment book capitalization - Crypto
AlphaTON Capital, judging by the linked Portage website, may be involved in biotech investments or cryptocurrencies. Both sectors are extremely risky and require specific capital management. The sector's total debt load chart provides investors with a starting point for assessing the level of financial risk a company bears.
Debt to book value of all companies in the market
AlphaTON Capital (formerly Portage Biotech) is a biopharmaceutical holding company investing in oncology research. Its business is managing a portfolio of risky scientific projects. This chart, reflecting the debt of an established economy, emphasizes that AlphaTON's capital comes from venture capital, not loans, and its success depends on breakthroughs in its portfolio companies.
P/E of the company, segment and market as a whole
P/E - AlphaTON Capital
This metric for AlphaTON Capital (formerly Portage Biotech) reflects its new strategy. If the company has moved into the crypto sector, its P/E will be highly volatile and speculative, dependent on digital asset prices. This is no longer a valuation of a biotech portfolio, but a bet on an entirely new, unpredictable market.
P/E of the market segment - Crypto
AlphaTON Capital is an investment firm focused on cryptocurrencies and blockchain technologies, managing a portfolio of digital assets and investing in promising projects. This chart shows the average valuation for the crypto sector, which helps understand how the market views this fund's investment strategy.
P/E of the market as a whole
Portage Biotech (ticker PRTG, not ATON) is a biotech company with a portfolio approach. It invests in several early-stage projects, diversifying risks. Its valuation reflects the overall potential of its portfolio. It is not tied to the overall economic trends shown in this chart, but rather depends on research data from several programs.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company AlphaTON Capital
AlphaTON Capital (formerly Portage Biotech) is an investment firm focused on biotech and crypto assets. This chart reflects investor expectations for the portfolio's value. The company's valuation depends on the success of its investments in promising but risky startups and on the dynamics of the cryptocurrency market.
%20P%2FE%20AlphaTON%20Capital&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-AlphaTON-Capital&v=1772513578143 "Chart of the company's future (projected) P/E AlphaTON Capital")
Future (projected) P/E of the market segment - Crypto
AlphaTON Capital is an investment firm focused on biotechnology and cryptocurrency. Its valuation relative to other investment firms reflects investors' perceptions of its ability to select successful projects. This demonstrates how the market views its expertise in these two high-risk, yet potentially high-reward sectors.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Crypto&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Crypto&v=1772513578146 "Future (projected) P/E graph of the market segment - Crypto")
Future (projected) P/E of the market as a whole
AlphaTON Capital, formerly known as Portage Biotech, is likely an investment firm focused on cryptocurrencies or biotech. Its success is directly dependent on the health of its chosen investment sector. This chart reflects investors' overall risk appetite, which is a key factor for both the crypto and biotech markets.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772513578164 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit AlphaTON Capital
AlphaTON Capital is an investment firm focused on biotech and cryptocurrency assets. Its financial results, illustrated by this chart, reflect the price movements of its portfolio investments and are subject to high volatility. This is a high-risk market play.
Profit of companies in the market segment - Crypto
AlphaTON Capital, formerly Portage Biotech, is a crypto-focused company. This chart shows the cumulative (and highly volatile) returns in the crypto sector. It demonstrates the potential of this young and risky market to generate sustainable returns, not just speculative growth, which is critical to AlphaTON's valuation.
Overall market profit
AlphaTON Capital (formerly Portage Biotech) is a biotech incubator investing in early-stage companies. Its success depends on its ability to select promising projects and the overall state of the biotech venture market. This schedule influences investor sentiment, but for ATON, scientific breakthroughs in its portfolio companies are more important.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company AlphaTON Capital
AlphaTON Capital is an investment company focused on cryptocurrencies and blockchain technologies. Its future profit forecast is directly dependent on the state of the cryptocurrency market. This chart reflects analyst expectations for the price movements of major cryptocurrencies and the success of the company's investment strategy.
%20profit%20of%20the%20company%20AlphaTON%20Capital&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-AlphaTON-Capital&v=1772513578325 "Graph of future (projected) profit of the company AlphaTON Capital")
Future (predicted) profit of companies in the market segment - Crypto
AlphaTON Capital is likely an investment firm, perhaps focused on biotechnology or cryptocurrency. The success of such firms depends on the quality of their investments and market conditions. This chart shows forecasts for the crypto sector. It helps assess the risk and volatility of the company's environment and how it compares to overall trends.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Crypto&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Crypto&v=1772513578355 "Graph of future (predicted) profits of companies in a market segment - Crypto")
Future (predicted) profit of the market as a whole
This chart illustrates investors' appetite for risky assets. For AlphaTON Capital, which focuses on biotech and cryptocurrency, this is a key factor. Economic growth and market optimism attract capital to these sectors. During downturns, investors prefer to shift to more conservative instruments.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772513578444 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - AlphaTON Capital
AlphaTON Capital, formerly Portage Biotech, is a biotech accelerator. This metric reflects how investors value its portfolio of investments in other biotech startups, not its own revenue.
P/S market segment - Crypto
AlphaTON Capital is an investment firm focused on cryptocurrencies and blockchain technologies. This chart shows the volatility of the crypto sector. It allows you to compare how the market views AlphaTON's investment strategy and its digital asset portfolio compared to other players in this rapidly changing and risky market.
P/S of the market as a whole
AlphaTON Capital Corp. is an investment firm that identifies and invests in promising technology startups, often in the blockchain and cryptocurrency space. Its "revenue" is the return on investment. This chart, reflecting real business valuations, serves as a backdrop for analyzing how investors evaluate venture capital investment structures.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company AlphaTON Capital
AlphaTON Capital is an investment firm focused on biotechnology and potentially crypto assets through its portfolio companies. Its future returns depend on the success of its investments. This chart reflects the market's valuation of its portfolio and its belief in the team's ability to select promising startups.
%20P%2FS%20AlphaTON%20Capital&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-AlphaTON-Capital&v=1772513578576 "The graph of the company's future (projected) P/S AlphaTON Capital")
Future (projected) P/S of the market segment - Crypto
AlphaTON Capital (formerly Portage Biotech) is a biotech accelerator that invests in promising early-stage oncology developments and helps them advance through clinical trials. Its valuation is based on the success of its portfolio companies. This chart shows how the market evaluates its investment model compared to other biotech holdings.
%20P%2FS%20market%20segment%20graph%20-%20Crypto&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Crypto&v=1772513578647 "Future (projected) P/S market segment graph - Crypto")
Future (projected) P/S of the market as a whole
This chart reflects expectations for the cryptocurrency and biotech markets. For AlphaTON Capital, a holding company with investments in these sectors, it serves as a summary indicator of risk appetite. Market optimism creates a favorable environment for both digital asset price growth and biotech funding.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772513578718 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales AlphaTON Capital
AlphaTON Capital (formerly Portage Biotech) is a company investing in early-stage oncology drug development. This chart reflects revenue from license or asset sales following successful completion of early-stage trials. The business model involves identifying and advancing promising candidates to a stage of interest to major pharmaceutical companies.
Sales of companies in the market segment - Crypto
AlphaTON Capital, formerly known as Portage Biotech, is a biotech company investing in and developing innovative oncology drugs. This chart reflects its financial activity in the sector. The company's business model focuses on discovering and advancing promising developments, making it an important element in the drug discovery ecosystem.
Overall market sales
AlphaTON Capital, formerly known as Portage Biotech, invests in promising cryptocurrency and technology projects. Its success is directly dependent on the state of the venture capital and cryptocurrency markets. This general economic activity influences investor appetite for risky assets, shaping the company's operating environment.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company AlphaTON Capital
AlphaTON Capital (formerly Portage Biotech) is an early-stage oncology drug development company. Its business model is focused on identifying promising assets and developing them. This chart represents aggregate analyst expectations for the company's entire investment portfolio and the likelihood of success for its clinical programs.
%20sales%20of%20the%20company%20AlphaTON%20Capital&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-AlphaTON-Capital&v=1772513578940 "Schedule of future (projected) sales of the company AlphaTON Capital")
Future (projected) sales of companies in the market segment - Crypto
AlphaTON Capital is a company operating in the cryptocurrency industry. This chart shows general expectations for the entire crypto sector. It reflects volatility, regulatory risks, and potential growth in the digital asset market, which are key factors determining AlphaTON's environment.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Crypto&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Crypto&v=1772513578954 "Schedule of future (projected) sales of companies in the market segment - Crypto")
Future (projected) sales of the market as a whole
AlphaTON Capital, formerly known as Portage Biotech, is a biotech company investing in and developing drugs across various therapeutic areas. Its success depends on the correct selection of assets and their development. This chart, reflecting the state of financial markets, influences the value of biotech assets and the company's ability to raise capital for its projects.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772513579065 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality AlphaTON Capital
AlphaTON Capital, formerly known as Portage Biotech, is a biotech incubator. This chart shows the profitability of its model. Profits are generated not from sales, but from the successful development and subsequent sale or licensing of assets—promising molecules advanced to a certain stage of clinical trials.
Market segment marginality - Crypto
AlphaTON Capital is an investment firm that invests in promising biotech projects. Its own profitability reflects the success of its portfolio companies. This chart, showing the average profitability in the crypto sector, helps assess the potential return of one of the areas of its investment strategy.
Market marginality as a whole
AlphaTON Capital is an investment firm focused on biotechnology and cryptocurrency. This overall market performance chart influences investor sentiment and asset valuations. During periods of growth and high returns, interest in riskier assets, such as biotech startups and crypto projects, increases, creating favorable conditions for AlphaTON.
Employees in the company, segment and market as a whole
Number of employees in the company AlphaTON Capital
AlphaTON Capital, formerly known as Portage Biotech, operated as a holding company, investing in a portfolio of biotech assets. This chart shows a small management team focused on selecting and overseeing investments rather than directly conducting research.
Share of the company's employees AlphaTON Capital within the market segment - Crypto
AlphaTON Capital, operating in the crypto sector, requires a team with unique skills. This chart shows the percentage of blockchain developers, analysts, and cybersecurity specialists the company attracts in this nascent industry. It reflects its ability to concentrate the talent needed to navigate the complex and rapidly changing world of digital assets.
Number of employees in the market segment - Crypto
AlphaTON Capital (formerly Portage Biotech) operates in the crypto sector, which is characterized by high volatility and rapid innovation. This chart shows that new financial technologies are creating demand for unique specialists—blockchain developers, tokenomics analysts, and lawyers who understand complex and evolving regulations.
Number of employees in the market as a whole
AlphaTON Capital (formerly Portage Biotech) represents the venture side of the biopharmaceutical industry. This chart reflects the end result—employment at large companies, but their growth would be impossible without seed capital from these investors. They finance the early, riskiest stages of research, creating future market leaders.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company AlphaTON Capital (ATON)
AlphaTON Capital (ATON) is a company involved in biotechnology investments and possibly digital assets. This chart reflects the investment firm's high capital intensity. The value lies in its asset portfolio (stocks, cryptocurrencies). The chart shows how much of these investment assets are held by a very small management team.
%20of%20the%20company%20AlphaTON%20Capital%20(ATON)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-AlphaTON-Capital-ATON&v=1772513579302 "Chart of market capitalization per employee (in thousands of dollars) of the company AlphaTON Capital (ATON)")
Market capitalization per employee (in thousands of dollars) in the market segment - Crypto
AlphaTON Capital is an investment firm focused on biotechnology and cryptocurrency. Here, value is created by the experience and insight of a small team of analysts and managers. The chart shows how the market evaluates their ability to pick successful projects. This is essentially an assessment of their investment talent.
%20by%20market%20segment%20-%20Crypto&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Crypto&v=1772513579337 "Market capitalization per employee (in thousands of dollars) by market segment - Crypto")
Market capitalization per employee (in thousands of dollars) for the overall market
AlphaTON Capital is an investment firm focused on biotechnology. This chart shows the average value the market assigns to a single employee. It illustrates a model where value is created through investment expertise.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772513579358 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company AlphaTON Capital (ATON)
AlphaTON Capital (formerly Portage Biotech) is a biotech holding company with a very small staff. This chart shows how effectively this management team allocates capital and manages its R&D asset portfolio (stakes in other biotechs) to generate profits.
%20Chart%20AlphaTON%20Capital%20(ATON)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-AlphaTON-Capital-ATON&v=1772513579405 "Company Profit Per Employee (in thousands of dollars) Chart AlphaTON Capital (ATON)")
Profit per employee (in thousands of dollars) in the market segment - Crypto
AlphaTON Capital, formerly known as Portage Biotech, is a biotech company investing in and developing a portfolio of oncology drugs. Its business model is similar to a pharmaceutical venture capital fund. Its earnings per employee can be highly volatile and depend on successful asset sales or drug launches, reflecting the effectiveness of investment decisions rather than operational performance.
%20in%20the%20market%20segment%20-%20Crypto&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Crypto&v=1772513579456 "Chart of profit per employee (in thousands of dollars) in the market segment - Crypto")
Profit per employee (in thousands of dollars) for the market as a whole
AlphaTON Capital (ATON) — (Little info, micro-cap, formerly Portage Biotech). Likely an investment holding company or SPAC focused on crypto or biotech. This chart shows the average profit per employee. It illustrates how the holding/investment model (very few employees, primary asset capital) differs from an operating business.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772513579517 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee AlphaTON Capital (ATON)
AlphaTON Capital is an investment company. For such a company, this chart reflects not operational efficiency, but rather the team's ability to manage capital. It reflects the income generated per employee from investment activities, whether in biotech or crypto assets.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-AlphaTON-Capital-ATON&v=1772513579567 "Sales chart per company employee AlphaTON Capital (ATON)")
Sales per employee in the market segment - Crypto
AlphaTON (formerly Portage Biotech) is a biotech company operating under an incubator model, developing several oncology projects. This chart shows the average revenue per employee in this segment. It serves as a productivity benchmark for commercial pharmaceutical companies and helps evaluate the effectiveness of AlphaTON's R&D portfolio management.
Sales per employee for the market as a whole
AlphaTON Capital — *The ticker data for ATON (formerly Portage Biotech) is unclear; the "Crypto" category may be new. It was previously a bio-holding company.* If it is a crypto company, this chart shows how efficiently their team (traders, engineers) generates revenue from mining, trading, or managing crypto assets.
Short shares by company, segment and market as a whole
Shares shorted by company AlphaTON Capital (ATON)
AlphaTON Capital (ATON) is apparently a shell company (formerly Portage Biotech) attempting to establish itself in the cryptocurrency and AI space. It's a classic microcap, hyped up. This chart shows the bets that it's a shell company. Bears believe the company has no real assets or technology, and is pure speculation.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-AlphaTON-Capital-ATON&v=1772513579704 "Short Shares Chart for the Company AlphaTON Capital (ATON)")
Shares shorted by market segment - Crypto
AlphaTON Capital (ATON) is a company investing in emerging technologies, including cryptocurrencies and biotechnology (via Portage Biotech). This chart shows the aggregate short interest in the cryptocurrency and speculative assets sector. Its high level reflects investor skepticism about risky assets and the viability of investing in this volatile space.
Shares shorted by the overall market
AlphaTON Capital (formerly Portage Biotech) is a biotech holding company investing in oncology drug development. Their business is venture capital in the biotech world. This chart measures overall fear. When investors are afraid, they sell off biotech. ATON shares are doubly vulnerable: both because of the risk of the drugs themselves and because of the decline in the value of their portfolio investments.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator AlphaTON Capital (ATON)
AlphaTON Capital (formerly Portage Biotech) is a holding company investing in a portfolio of biotech startups. Its price is a bet on the success of its portfolio companies. This indicator measures how the market values the portfolio, showing "overheated" (above 70) for successful trials or "oversold" (below 30) for failures.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-AlphaTON-Capital-ATON&v=1772513579745 "RSI 14 indicator chart for the company's stock AlphaTON Capital (ATON)")
RSI 14 Market Segment - Crypto
AlphaTON Capital (affiliated with Portage Biotech) is a company focused on cryptocurrency and biotech. This chart measures the overall excitement and decline in the cryptocurrency sector. It helps determine whether the industry as a whole is overheated due to hype or oversold amid regulatory pressure, allowing one to assess ATON's performance.
RSI 14 for the overall market
For AlphaTON Capital, a cryptocurrency firm, this chart is an indicator of risk appetite. Market euphoria in the stock market often spills over into speculative assets, including cryptocurrencies, attracting clients. In moments of panic, investors flee all risky assets, and a "crypto winter" freezes activity in the sector.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast ATON (AlphaTON Capital)
AlphaTON Capital is an investment firm focused on blockchain and cryptocurrency assets. This chart shows the average 12-month forecast of analysts. Their target price (if any) is highly speculative and depends entirely on crypto market volatility.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-ATON-AlphaTON-Capital&v=1772513579888 "A chart showing analyst consensus forecasts for the expected stock price. ATON (AlphaTON Capital)")
The difference between the consensus estimate and the actual stock price ATON (AlphaTON Capital)
AlphaTON (Portage Biotech) is a biotech holding company that invests in and develops a portfolio of immuno-oncology drugs. This chart shows the upside and downside potential analysts see in the stock. It measures the gap between the price and forecast, reflecting their "summary" valuation of this R&D portfolio.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-ATON-AlphaTON-Capital&v=1772513579910 "A chart showing the difference between the consensus forecast and the actual stock price. ATON (AlphaTON Capital)")
Analyst consensus forecast for stock prices by market segment - Crypto
AlphaTON (formerly Portage Biotech) is a speculative holding company that, after pivoting from biotech, focused on investing in crypto assets and blockchain. This chart displays analysts' overall expectations for the entire crypto sector. It shows whether experts believe a new bull cycle is possible in the cryptocurrency market.
Analysts' consensus forecast for the overall market share price
AlphaTON Capital (formerly Portage Biotech) is a holding company in transition, focusing on cryptocurrencies and fintech. This chart shows the overall market "risk appetite." For ATON, a speculative company focused on crypto assets, overall market optimism (risk appetite) is critical to attracting investor attention.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index AlphaTON Capital
AlphaTON (Portage) is a biotech incubator. They don't have a single lab; their business is identifying, funding, and managing a portfolio of R&D startups (subsidiaries), each with its own drug (primarily in immuno-oncology). This chart is a summary indicator of their portfolio strategy. It reflects their ability to select winners and their reliance on exits (subsidiary sales).
AKIMA Market Segment Index - Crypto
AlphaTON Capital (ATON), likely associated with Portage Biotech, is a company operating in the cryptocurrency or fintech space, possibly as an investment fund or technology provider. The chart shows the average index for the segment, helping investors assess how ATON compares to the average in this volatile crypto sector.
The AKIM Index for the overall market
AlphaTON Capital (Portage Biotech) is a company investing in and developing a portfolio of immuno-oncology assets. It operates as an accelerator. This chart, reflecting the market average, provides a macro backdrop. It helps assess how this drug development model compares to overall economic trends in biotech.
